Chardan Capital analyst Keay Nakae maintained Dyne Therapeutics with a Buy and lowered the price target from $50 to $38.

Dyne also reported new positive long-term data from adult DM1 patients enrolled in the randomized, placebo-controlled multiple ascending dose (MAD) portion of the DYNE-101 ACHIEVE trial, including ...

Kristen Bell and Kelly Reilly share a birthday today. Check out our photo slideshow of celebrities and other famous people with birthdays on July 18, 2025 and find out a fun fact about each person.

Taco Bell gives Crispy Chicken fans a new menu option. This twist on a Southern favorite is fiery, sweet and tangy.

Key Points Interactive Brokers reports earnings after the bell. The company’s shares have risen more than 30% for the year thanks in large part due to significant account growth. Updates will ...

"The Luxe Value Menu test is a natural extension of Taco Bell’s evolving value story and commitment to providing accessible options for all lifestyles and cravings,” reads the press release.

Futures tracking the Nasdaq and the S&P 500 rose on Thursday, as strong results from Taiwan's TSMC boosted chipmakers after a rollercoaster session marked by concerns about the Federal Reserve's ...

The Nasdaq-100 Index performed very well in the month of June. The two top performers saw their prices increase nearly 5 times the index. Micron Technology and Arm Holdings were major winners for ...

The Road to NASDAQ: MH Markets Embarks on IPO Journey Inspired by Waton Financial's successful listing, MH Markets has officially initiated its NASDAQ IPO process.

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) is one of the best oversold NASDAQ stocks to buy now. On June 12, Jefferies analyst Dennis Ding maintained a bullish stance on NewAmsterdam Pharma ...